Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

Two in five FS organizations got involved with cryptos in H1, showing growing confidence in digital currencies technology, says GlobalData

20% of financial services (FS) industry insiders reported having cryptos as part of their organizations’ core operation in a sentiment poll* conducted globally across GlobalData’s FS news media sites during the first half (H1) of 2025. An additional 20% are expected to follow suit, either having implementation plans in place (6%), or looking into strategies […]
Read more

Coca-Cola ad campaigns shift from personal refreshment to collective connection, reveals GlobalData

The Coca-Cola Company has undergone a notable transformation in its advertising themes and focus areas between Q2 (April to June) and Q3 (July to September) of 2025. The latest analyses reveal a strategic pivot from individualistic messaging centered around personal breaks and revitalization to a more community-centric approach that emphasizes togetherness, cultural relevance, and shared […]
Read more

US tariff and pricing reforms drive pharma localization and spur outsourcing-led investment shifts, says GlobalData

Escalating US tariff and pricing reforms are pushing pharmaceutical companies to localize manufacturing and rethink their investment priorities, fueling a surge in outsourcing-led strategies and targeted acquisitions. The recent deals in obesity and liver disease, Pfizer’s purchase of Metsera and Roche’s acquisition of 89bio, underscore how dealmaking is increasingly shaped by policy incentives, tariff exposure, […]
Read more

High-value VC investments concentrate within top 10 markets in Q1-Q3 2025 as US extends dominance, reveals GlobalData

High-value* venture capital (VC) activity during the first three quarters (Q1-Q3) of 2025 remained overwhelmingly clustered within the world’s top 10 investment markets, with the US extending its dominance across both deal volume and value. The sharp concentration of mega-deals signals a maturing late-stage funding landscape, where capital increasingly flows toward established ecosystems, reshaping competitive […]
Read more

Sovato Series B signals rising confidence in remote-capable surgical robotics, says GlobalData

Remote-enabled surgical robotics is entering a pivotal growth phase as next-generation platforms integrate teleoperation, advanced imaging, and high-speed connectivity to expand clinical reach. Sovato’s latest Series B financing reinforces this momentum, reflecting rising investor confidence in digitally integrated systems that enhance access, precision, and workflow efficiency, signalling a broader shift toward robotics technologies poised to […]
Read more

Space manufacturing shows potential for next-generation therapies, says GlobalData

The space environment is rapidly emerging as a vital platform for scientific discovery and biomedical advancement. As space becomes more accessible, pharmaceutical and biotech companies are focusing on low-Earth orbit to explore new opportunities in drug development and disease modelling and therapeutic design, according to GlobalData, a leading data and analytics company. Microgravity affects biological […]
Read more

APAC equities steady in 2025 as AI boom and easing trade tensions support market sentiment, says GlobalData

Asia-Pacific equities remained resilient through 2025 as trade uncertainty, political shifts, and the rapid acceleration of artificial intelligence (AI) reshaped regional markets. The standout driver was a strong AI-led rise in technology and semiconductor stocks, helping cushion broader volatility. As 2026 approaches, contrasting monetary paths and renewed tariff risks point to another period of sharp […]
Read more

High-value deals drive venture capital activity amid overall slowdown during Q1-Q3 2025, reveals GlobalData

Global venture capital (VC) activity in Q1-Q3 2025 shows a clear shift in strategy as overall deal volume year-on-year (YoY) declined mainly due to an 11% drop in low-value (≤ $10 million) investments. However, high-value investments (>$100 million) rose 17% and billion-dollar deals volume also increased. This reflects investors’ focus on fewer but stronger opportunities […]
Read more

Magnificent 7 ramp-up R&D and capex as AI shift drives $2 trillion revenue surge, reveals GlobalData

The Magnificent 7—Apple, Microsoft, Alphabet, Amazon, Meta, NVIDIA, and Tesla—ended their latest fiscal year with an unmistakable theme: escalating R&D intensity and capital spending aligned around artificial intelligence (AI), even as cash balances normalize post-COVID-19 pandemic. The group collectively generated over $2.08 trillion in revenue, up about 14% year-on-year (YoY), underscoring the resilience of the […]
Read more

Sutaray NMPA approval marks major milestone in China HER2-positive breast cancer market, says GlobalData

The National Medical Products Administration (NMPA) in China has recently approved Sichuan Kelun Biotech Biopharmaceutical’s Sutaray (trastuzumab botidotin) for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer (BC). The move marks a pivotal advance in the nation’s oncology market as domestic innovation accelerates in high-need breast cancer segments, says GlobalData, a […]
Read more

Metsera takeover battle reflects Novo Nordisk and Pfizer push to challenge Lilly’s obesity drug dominance, says GlobalData

Following the news that Novo Nordisk made an unsolicited acquisition bid for US-based obesity biotech Metsera Therapeutics, which was subsequently rejected by Pfizer, but designated by Metsera as a “Superior Company Proposal” to the one previously agreed between Metsera and Pfizer: Jay Patel, Senior Pharma Analyst at GlobalData, a leading data and analytics company, offers […]
Read more

Top 20 global biopharmaceutical companies report 4% market capitalization growth in Q3 2025, reveals GlobalData

The top 20 global biopharmaceutical companies experienced mixed individual market capitalization performances in Q3 2025, with those experiencing robust pipeline progress reaping success. This resulted in a 4% quarter-on-quarter (QoQ) increase in their combined market capitalization from $3.7 trillion on 30 June 2025 to $3.8 trillion on 30 September 2025, reveals GlobalData, a leading data […]
Read more

Agentic and GenAI adoption across capital markets rises but financial institutions temper expectations, finds Celent, a GlobalData company

54% of survey respondents expect to have Agentic AI in production next year GenAI sentiment down YoY as industry focuses on ROI Financial institutions across capital markets indicates respondents are taking a reality check when it comes to expectations around GenAI and Agentic AI. While financial institutions quickly implemented the more straight-forward use cases such […]
Read more

Vietnam card payments market to grow by 5% in 2025 to reach $48.7 billion, forecasts GlobalData

The card payments market in Vietnam is expected to grow by 5% to reach VND1.2 quadrillion ($48.7 billion) in 2025, supported by the constant consumer shift towards non-cash payments. While cash remains dominant, strong government support, growing card penetration, and evolving consumer preferences are supporting the country’s transition to a less cash-dependent economy and reshaping […]
Read more

Gen AI and agentic AI drive next stage in trade finance digitization, says Celent, a GlobalData company

Trade finance remains slowed by manual processes, paper documents, and persistent fraud, delaying operations by days and increasing risk. Emerging generative AI (GenAI) and agentic AI applications offer banks an opportunity to digitize critical workflows, improve efficiency, strengthen risk detection, and enhance customer experience, potentially transforming trade finance operations and creating a competitive edge in […]
Read more

Japan ultrasound systems market to reach $1.265 billion in 2034, forecasts GlobalData

Japan’s medical imaging field is progressing steadily with broader adoption of ultrasound diagnostic systems. Within this context, Japan’s ultrasound systems market is projected to reach $1.265 billion in 2034, according to GlobalData, a leading data and analytics company. GlobalData’s latest report, “Ultrasound Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to […]
Read more

Armata AP-SA02 shows promise for SAB in Phase IIa trial, underscoring growing potential of phage therapy, says GlobalData

Armata Pharmaceuticals’ investigational phage therapy, AP-SA02, demonstrated earlier resolution in patients with Staphylococcus aureus bacteremia (SAB) in a Phase IIa trial, reinforcing the growing clinical promise of bacteriophage-based treatments. The findings highlight the therapy’s potential to address antibiotic resistance and provide a new treatment option for patients with serious bloodstream infections, says GlobalData, a leading […]
Read more
1 … 15 16 17 18 19 … 206